5 of Last Week's Biggest Winners


What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.


March 8

Weekly Gain




MGIC Investment






James River Coal






Source: Barron's.

Vical -- a biotech working on a metastatic melanoma treatment that's in the late stages of clinical studies -- popped nicely higher after impressing investors at the Cowen and Company 33rd Annual Health Care Conference in Boston on Wednesday.

MGIC wowed investors with a 39% surge a week earlier, and it kept the party going with a 30% climb this time around. Mortgage insurance companies have been soaring as the housing market firms up, since that means less risk for the values of the homes that they're insuring. Rival MBIA also went along for the ride, moving 21% higher this past week on the same wave of improving fundamentals.

James River Coal initially tanked after posting a wider-than-expected quarterly deficit, but its plans to idle a few mines should save money at a time when the coal producer can certainly use it. After slumping through the first four days of the week, James River burst into positive territory with a 17% pop on Friday.

Amarin posted a much smaller deficit than Wall Street was expecting two weeks ago, but momentum is building for this quarter's launch of its flagship Vascepa drug. The first approved medication for the treatment of high triglyceride levels should mean big things for Amarin, and having nearly 25 million shares sold short should add fuel to any rally.

Keep the good vibes coming
If you're on the lookout for some currently intriguing energy plays, check out The Motley Fool's "3 Stocks for $100 Oil." You can get free access to this special report by clicking here.

The article 5 of Last Week's Biggest Winners originally appeared on Fool.com.

Longtime Fool contributor Rick Munarriz and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.